Parker, Michael W.

AMPK β Subunit Targets Metabolic Stress Sensing to Glycogen

Polekhina, G., Gupta, A., Michell, B. J., van Denderen, B., Murthy, S., Feil, S. C., Jennings, I. G., Campbell, D. J., Witters, L. A., Parker, M. W., et al. (2003) · Current Biology

Metabolism, Diabetes, and CancerGlycogen Storage Diseases and Myoclonus

Cited by 423

Oncogenic protein interfaces: small molecules, big challenges

Nero, T. L., Morton, C. J., Holien, J. K., Wielens, J., & Parker, M. W. (2014) · Nature Reviews Cancer

Chemical Synthesis and AnalysisProtein Degradation and Inhibitors

Cited by 312

Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia

Morrow, M. R., Batchuluun, B., Wu, J., Ahmadi, E., Leroux, J. M., Mohammadi-Shemirani, P., Desjardins, E. M., Wang, Z., Tsakiridis, E. E., Lavoie, D. C. T., et al. (2022) · Cell Metabolism

Liver Disease Diagnosis and TreatmentCancer, Lipids, and Metabolism

Cited by 199

Molecular Dissection of the Interaction between Amyloid Precursor Protein and Its Neuronal Trafficking Receptor SorLA/LR11

Andersen, O. M., Schmidt, V., Spoelgen, R., Gliemann, J., Behlke, J., Galatis, D., McKinstry, W. J., Parker, M. W., Masters, C. L., Hyman, B. T., et al. (2006) · Biochemistry

Alzheimer's disease research and treatmentsCellular transport and secretion

Cited by 178

Bapineuzumab captures the N-terminus of the Alzheimer's disease amyloid-beta peptide in a helical conformation

Miles, L. A., Crespi, G. A. N., Doughty, L., & Parker, M. W. (2013) · Scientific Reports

Alzheimer's disease research and treatmentsMonoclonal and Polyclonal Antibodies Research

Cited by 130

Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators

Flierl, U., Nero, T. L., Lim, B., Arthur, J. F., Yao, Y., Jung, S. M., Gitz, E., Pollitt, A. Y., Zaldivia, M. T. K., Jandrot-Perrus, M., et al. (2015) · Journal of Experimental Medicine

Platelet Disorders and TreatmentsHeparin-Induced Thrombocytopenia and Thrombosis

Cited by 114

Vγ9Vδ2 T cells recognize butyrophilin 2A1 and 3A1 heteromers

Fulford, T. S., Soliman, C., Castle, R. G., Rigau, M., Ruan, Z., Dolezal, O., Seneviratna, R., Brown, H. G., Hanssen, E., Hammet, A., et al. (2024) · Nature Immunology

T-cell and B-cell Immunologyvaccines and immunoinformatics approaches

Cited by 57